Medrio News Roundup: January 2018

Welcome to the Medrio News Roundup, where we brief you on a sample of recent events and developments taking place around the industry. This recurring update functions on popular demand – the stories in the post come from the articles in our social media feeds that garnered the most attention from our readers and followers. Your likes, clicks, and retweets decide which stories make it beyond your newsfeed and onto our blog.

This month, we bring you news about a prediction for increased use of CROs by drug manufacturers, an in-depth analysis of outsourcing trends that emerged in 2017, and a report on an important change in Apple’s mHealth strategy. Take a look, and tune in for the next roundup in a month!

1. Drug manufacturers increasingly use CROs to reduce R&D costs

In response to additional pressure to accelerate the drug development process and reduce R&D costs, drug manufacturers increasingly look to CROs/CMOs to handle some or all of their research and manufacturing needs. In the article we shared, an industry leader from Massachusetts predicts that trend won’t slow down in 2018 and points out that growth and venture capital investment in the biopharma sector in Massachusetts is especially strong.

2. Analyzing the top clinical outsourcing trends of 2017

Competition in the clinical development services market increased in 2017 as the category saw continuous M&A activity, resulting in consolidation and in CROs using geographic reach, full-service capability, technology and other differentiators to compete for market share. In this in-depth analysis, an industry analyst covers category spending and growth, drivers behind clinical outsourcing, the outsourced vs. in-house trend, and more.

3. Apple to add ECG sensor to Apple Watch, boosting its mHealth platform

Apple is reportedly working on an ECG sensor for the Apple Watch, a move that would give the device a stronger mHealth platform and possibly bridge the gap between clinical uses and consumer engagement. This report describes how Apple’s move pits it against developers of medical-grade ECG wearables and further pushes consumer wearables into the remote patient monitoring landscape.

That’s all for this roundup! We’ll have three more stories for you next month. In the meantime, check out this blog every week for new insights into EDC and clinical research.

| |

Recent Posts